CICADA Stories at the Bloomsbury TheatreMany people with chronic conditions or disabilities, particularly those from minoritized ethnic groups, faced obstacles before the pandemic in accessing or utilizing networks of support, health and social care. During the pandemic, some issues increased disproportionately in, and widened the inequalities gap between, people with disabilities from minoritized ethnic groups and those without disabilities and from the indigenous white British population.
Our ethos, using an asset- and strengths-based focus, was to learn from and build upon what participants said worked well for them when coping with issues or managing their health, rather than to impose external solutions. We focused on health and social care, informal networks, and access to vital ‘resources’ such as food and medicine and foregrounded the interplay of ethnicity, disability and citizenship status alongside other demographic factors.
These suggested participants felt vulnerable at the end of the COVID-19 restrictions. The pandemic’s social and financial impact appears to compound inequities, leaving many anxious about the future.
aksoyundan FangWeiWu LinseedAndPom
TCRU_UCL UCLSocRes IoeResearch IOE_SSRU
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Autoimmune gene expression profiling of fingerstick whole blood in Chronic Fatigue Syndrome - Journal of Translational MedicineBackground Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating condition that can lead to severe impairment of physical, psychological, cognitive, social, and occupational functions. The cause of ME/CFS remains incompletely understood. There is no clinical diagnostic test for ME/CFS. Although many therapies have been used off-label to manage symptoms of ME/CFS, there are limited, if any, specific therapies or cure for ME/CFS. In this study, we investigated the expression of genes specific to key immune functions, and viral infection status in ME/CFS patients with an aim of identifying biomarkers for characterization and/or treatment of the disease. Methods In 2021, one-hundred and sixty-six (166) patients diagnosed with ME/CFS and 83 healthy controls in the US participated in this study via a social media-based application (app). The patients and heathy volunteers consented to the study and provided self-collected finger-stick blood and first morning void urine samples from home. RNA from the fingerstick blood was tested using DxTerity’s 51-gene autoimmune RNA expression panel (AIP). In addition, DNA from the same fingerstick blood sample was extracted to detect viral load of 4 known ME/CFS associated viruses (HHV6, HHV7, CMV and EBV) using a real-time PCR method. Results Among the 166 ME/CFS participants in the study, approximately half (49%) of the ME/CFS patients reported being house-bound or bedridden due to severe symptoms of the disease. From the AIP testing, ME/CFS patients with severe, bedridden conditions displayed significant increases in gene expression of IKZF2, IKZF3, HSPA8, BACH2, ABCE1 and CD3D, as compared to patients with mild to moderate disease conditions. These six aforementioned genes were further upregulated in the 22 bedridden participants who suffer not only from ME/CFS but also from other autoimmune diseases. These genes are involved in T cell, B cell and autoimmunity functions. Furthermore, IKZF3 (Aiolos) and IKZF2
Source: BioMedCentral - 🏆 22. / 71 Read more »